| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-06-27 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
271,174 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-06-27 |
4 |
AS |
$38.69 |
$735,169 |
D/D |
(19,000) |
252,174 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-15 |
4 |
D |
$38.80 |
$154,657 |
D/D |
(3,986) |
248,188 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-17 |
4 |
D |
$38.80 |
$82,334 |
D/D |
(2,122) |
246,066 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-21 |
4 |
D |
$39.13 |
$50,126 |
D/D |
(1,281) |
244,785 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-25 |
4 |
OE |
$4.90 |
$19,017 |
D/D |
3,881 |
229,666 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-25 |
4 |
AS |
$38.37 |
$728,964 |
D/D |
(19,000) |
225,785 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-15 |
4 |
D |
$9.75 |
$38,864 |
D/D |
(3,986) |
225,680 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-17 |
4 |
D |
$9.31 |
$19,756 |
D/D |
(2,122) |
223,558 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-10-21 |
4 |
D |
$10.36 |
$13,271 |
D/D |
(1,281) |
222,277 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
460,000 |
682,277 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-15 |
4 |
D |
$8.85 |
$25,603 |
D/D |
(2,893) |
631,883 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-20 |
4 |
D |
$10.35 |
$9,594 |
D/D |
(927) |
630,956 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2012-04-21 |
4 |
D |
$10.35 |
$9,615 |
D/D |
(929) |
630,027 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-06-30 |
4 |
D |
$7.40 |
$1,463,454 |
D/D |
(197,764) |
432,263 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
457,263 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
23,292 |
23,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2017-07-24 |
4 |
A |
$0.00 |
$0 |
I/I |
3,878,441 |
3,803,906 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
20,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
17,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2018-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
11,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-01-18 |
4 |
B |
$5.37 |
$1,024,999 |
I/I |
190,875 |
3,994,781 |
2.64 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
6,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2019-12-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,292 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
67,569 |
68,861 |
0 |
- |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
